Get the Stockscreener App
0.0608
10.14%
0.0056
After Hours:
.06
-0.0008
-1.32%
Windtree Therapeutics Inc stock is traded at $0.0608, with a volume of 76,350.
It is up +10.14% in the last 24 hours and down -66.22% over the past month.
WINDTREE THERAPEUTICS NEW
See More
Previous Close:
$0.0552
Open:
$0.0609
24h Volume:
76,350
Relative Volume:
1.31
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-14.67M
P/E Ratio:
-0.000278
EPS:
-218.8129
Net Cash Flow:
$-15.19M
1W Performance:
+3.05%
1M Performance:
-66.22%
6M Performance:
-97.23%
1Y Performance:
-98.94%
1-Day Range:
$0.055
$0.0609
1-Week Range:
$0.0518
$0.0634
52-Week Range:
$0.0518
$0.19
Windtree Therapeutics Inc Stock (WINT) Company Profile
Name
Windtree Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare WINT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
0.0608 | 0 | 0 | -14.67M | -15.19M | -218.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-20 | Initiated | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc Stock (WINT) Latest News
Windtree Therapeutics to purchase Arizona company - Pennsylvania Business Report -
Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime - MSN
Scottsdale-based real estate fintech CommLoan to be acquired by Philadelphia-area firm - The Business Journals
Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference - MSN
Windtree Therapeutics to buy commercial real estate fintech in latest diversification attempt - The Business Journals
Windtree Therapeutics Issues Convertible Notes for Acquisition - The Globe and Mail
Windtree Therapeutics signs letter of intent to acquire CommLoan By Investing.com - Investing.com Nigeria
Windtree Therapeutics To Acquire CommLoan - citybiz
Windtree Therapeutics announces it has signed a letter of intent to acquire CommLoan - marketscreener.com
Windtree Therapeutics (WINT) to Acquire CommLoan: A Strategic Mo - GuruFocus
Windtree Therapeutics signs letter of intent to acquire CommLoan - Investing.com
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space - The Manila Times
Windtree Therapeutics (WINT) signs LOI to acquire fintech lender CommLoan - Stock Titan
WINT SEC FilingsWindtree Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal - Investing.com Nigeria
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal By Investing.com - Investing.com South Africa
Windtree Therapeutics (WINT) raises $857K via 2026 convertible notes for CommLoan LOI - Stock Titan
Windtree Therapeutics, Inc. signed a letter of intent to acquire CommLoan, Inc. - marketscreener.com
Windtree Therapeutics Delays Quarterly Report Filing - MSN
Windtree Expands Global Patent Portfolio as Heart Failure Pipeline Gains Momentum - MSN
Windtree Signals Possible Windfall as Partner Revives Lifesaving Infant Lung Treatments - MSN
Warrington’s Windtree Therapeutics Calls Off Acquisition of Titan Environmental Services - BUCKSCO.Today
Windtree Secures $7.5M as Planned Environmental Services Deal Is Called Off - MSN
Windtree Therapeutics Approves Key Financial Structure Changes - MSN
Why Windtree Therapeutics Inc. stock could benefit from AI revolution2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Can Windtree Therapeutics Inc. stock hit analyst price targetsQuarterly Investment Review & Precise Buy Zone Identification - newser.com
Why Windtree Therapeutics Inc. stock is recommended by analystsNew Guidance & High Conviction Investment Ideas - newser.com
Will Windtree Therapeutics Inc. price bounce be sustainableMarket Risk Summary & Expert Verified Movement Alerts - newser.com
What’s next for Windtree Therapeutics Inc. stock priceTake Profit & Consistent Growth Equity Picks - newser.com
Is Windtree Therapeutics Inc. stock a good choice for value investorsJobs Report & Verified Momentum Stock Ideas - newser.com
Live market analysis of Windtree Therapeutics Inc.2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Using portfolio simulators with Windtree Therapeutics Inc. includedEarnings Growth Summary & Entry Point Strategy Guides - newser.com
Windtree Therapeutics Inc Stock (WINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Cap:
|
Volume (24h):